๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Ribavirin treatment facilitates weaning from immunosuppression in liver transplant recipients with recurrent hepatitis C

โœ Scribed by M. Angelico; R. Lionetti; F. Casarelli; S. Zazza; T. Manzia; D. Di Paolo; A. Petrolati; C.U. Casciani; G. Tisone

Book ID
117372446
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
164 KB
Volume
38
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Sustained viral response to interferon a
Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C
โœ Manal F. Abdelmalek; Roberto J. Firpi; Consuelo Soldevila-Pico; Alan I. Reed; Al ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 237 KB ๐Ÿ‘ 1 views

Recurrent hepatitis C infection is an important cause of progressive fibrosis, cirrhosis, and graft loss following orthotopic liver transplantation. Treatment for posttransplant recurrence of hepatitis C with interferon-based therapy is difficult but results in loss of detectable virus in up to 30%

Anemia in liver transplant recipients un
Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C
โœ Sammy Saab; Mina K. Oh; Ayman B. Ibrahim; Francisco Durazo; Steven Han; Hasan Ye ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 166 KB ๐Ÿ‘ 1 views

Adherence to antiviral therapy is essential to achieve sustained virological responses in patients treated for hepatitis C. An important limitation to use of appropriate doses of ribavirin is development of anemia. The aim of this study is to identify risk factors associated with anemia in liver tra